logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9040483 B1

PDFFull Text
Date of Patent:
May. 26, 2015

Filed:

Jul. 17, 2012

Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor

Applicants:

Paul F. Glidden, San Diego, CA (US);

Alison J. Pilgrim, Castillon-du-Gard, FR;

Stephen R. Hanson, Edmonds, WA (US);

Inventors:

Paul F. Glidden, San Diego, CA (US);

Alison J. Pilgrim, Castillon-du-Gard, FR;

Stephen R. Hanson, Edmonds, WA (US);

Assignee:

BIOVASCULAR, INC., La Jolla, CA (US);

Attorneys:

Nelson Mullins Riley & Scarborough LLP

Jane E. Remillard, Esq.

Cynthia L. Kanik

Primary Examiner:

Sean Basquill

Assistant Examiner:

Andrew S Rosenthal

Int. Cl.
CPC ...
A61P 7/02 (2006.01); C07D 239/72 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 31/00 (2006.01); A61K 31/519 (2006.01); A61L 27/02 (2006.01); A61L 27/20 (2006.01); A61L 27/22 (2006.01); A61L 27/34 (2006.01); A61L 27/54 (2006.01); A61L 27/56 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 239/72 (2013.01); A61K 9/4808 (2013.01); A61K 9/5078 (2013.01); A61K 31/00 (2013.01); A61K 31/519 (2013.01); A61L 27/025 (2013.01); A61L 27/20 (2013.01); A61L 27/227 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); C07D 487/04 (2013.01); A61L 2300/42 (2013.01); A61L 2300/602 (2013.01); A61L 2300/608 (2013.01); A61L 2300/622 (2013.01); A61L 2300/63 (2013.01); A61L 2420/08 (2013.01);
Abstract

Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.

Find Patent Forward Citations

Glidden, Paul. (2015). Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor (U.S. Patent No. 9040483). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9040483

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…